Furathiocarb

Synonyms: 呋线威
Furathiocarb 是一种氨基甲酸酯类前杀虫剂 (insecticide),也是一种接触性变应原,常用于接触性过敏的相关研究,能诱导耳淋巴结细胞中 MHC II 类阳性 B 细胞显著增殖,并诱导产生 Th1 细胞因子 (如 IL-2、TNF-γ 和 IFN-γ),但不引起小鼠的呼吸道过敏;Furathiocarb 经离体大鼠腹部皮肤吸收后会完全代谢为克百威,其渗透量随时间和剂量增加而上升,且其乳油 (EC) 制剂和可湿性粉剂 (WP) 制剂的皮肤渗透率均高于 Furathiocarb,两种制剂之间无显著差异。
产品编号: MS-Z61215 CAS No.: 65907-30-4 分子式: C18H26N2O5S 分子量: 382.48
MolStrong 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
规格 价格 是否有货 数量 购物车
5mg
询价
3-5 天
10mg
询价
3-5 天
25mg
询价
3-5 天
50mg
询价
3-5 天
100mg
询价
3-5 天
200mg
询价
询价
500mg
询价
询价

产品描述

Furathiocarb 是一种氨基甲酸酯类前杀虫剂 (insecticide),也是一种接触性变应原,常用于接触性过敏的相关研究,能诱导耳淋巴结细胞中 MHC II 类阳性 B 细胞显著增殖,并诱导产生 Th1 细胞因子 (如 IL-2、TNF-γ 和 IFN-γ),但不引起小鼠的呼吸道过敏;Furathiocarb 经离体大鼠腹部皮肤吸收后会完全代谢为克百威,其渗透量随时间和剂量增加而上升,且其乳油 (EC) 制剂和可湿性粉剂 (WP) 制剂的皮肤渗透率均高于 Furathiocarb,两种制剂之间无显著差异。

生物实验数据

生物活性 Furathiocarb is a carbamate pro-insecticide and a contact allergen commonly used in studies related to contact allergy; it significantly induces the proliferation of MHC class II-positive B cells in ear lymph node cells and the production of Th1 cytokines (such as IL-2, TNF-γ, and IFN-γ), but does not cause respiratory allergy in mice; after absorption through the abdominal skin of isolated rats, Furathiocarb is completely metabolized to carbofuran, with its permeation increasing over time and with dose, and both its emulsifiable concentrate (EC) and wettable powder (WP) formulations exhibit higher skin permeation rates than Furathiocarb, with no significant difference between the two formulations.
体内研究
(In Vivo)

Furathiocarb (0.1-3%;局部给药;每日 1 次;连续 3 天) 可在雌性 CBA/Jn 小鼠中发挥皮肤致敏剂作用,在 3%剂量下可观察到局部淋巴结试验阳性反应,其 EC3 值为 1.08%。
Furathiocarb (1%(致敏)、0.01-0.1%(激发);致敏采用局部给药,激发采用气管内给药;致敏于第 1-3、8-10、15-17 天进行,激发于第 31 天单次给药) 在雌性 BALB/c 小鼠经长期皮肤致敏及气管内激发后,肺相关淋巴结无显著 Th2 激活,未诱导出呼吸道变应原免疫特征。

Animal Model: BALB/c mice with Allergic contact dermatitis (female, 7 weeks old)
Dosage: 1% (sensitization); 0.01% (challenge), 0.1% (challenge)
Administration: topical; on days 1-3, 8-10, 15-17 (sensitization); topical; single dose on day 31 (challenge)
Result: Did not cause statistically significant increases in total serum IgE levels in any furathiocarb-treated groups relative to controls.
Caused statistically significant increases in total lymphocyte counts, MHC Class II-positive B-cell counts, and IgE-positive B-cell counts in auricular lymph nodes at 0.1% challenge dose (after 1% sensitization) relative to control groups.
Caused IgE-positive B-cell counts to be significantly higher than in the low-dose challenge group at 0.1% challenge dose (after 1% sensitization).
Caused statistically significant increases in total lymphocyte counts and MHC Class II-positive B-cell counts in auricular lymph nodes at 0.01% challenge dose (after 1% sensitization) relative to non-sensitized controls.
Induced statistically significant increases in Th1 cytokines (IL-2, TNF-α, IFN-γ) and Th2 cytokines (IL-4, IL-5, IL-10, IL-13) in ex situ culture of auricular lymph node cells relative to controls, though Th2 cytokine responses were milder than those induced by 2,4-D.
Animal Model: BALB/c mice with Respiratory allergy (female, 7 weeks old)
Dosage: 1% (sensitization); 0.01% (challenge), 0.1% (challenge)
Administration: topical; on days 1-3, 8-10, 15-17 (sensitization); intratracheal; single dose on day 31 (challenge)
Result: Did not cause statistically significant increases in total IgE levels in serum or BALF in any furathiocarb-treated groups relative to controls.
Did not cause elevations in total or differential cell counts (eosinophils, neutrophils, macrophages) in BALF, aside from a mild, statistically significant increase in MIP-1β levels in the high-dose challenge group relative to controls.
Did not cause statistically significant increases in IgE-positive B-cell or MHC Class II-positive B-cell counts in lung-associated lymph nodes.
Did not induce statistically significant increases in Th2 cytokines (IL-4, IL-10, IL-13) in ex situ culture of lung-associated lymph node cells relative to controls.

化学信息

分子量 382.48
分子式 C18H26N2O5S
CAS No. 65907-30-4
别名 呋线威

储存&溶解度

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

运输条件 Room temperature in continental US; may vary elsewhere.

计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
起始浓度(M)× 起始体积(L)= 最终浓度(M)× 最终体积(L)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
溶液体积 = 质量 ÷ 配液浓度
Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration
÷
分子量计算器
Enter the chemical formula of the compound to calculate its molar mass and elemental composition
g/mol

体内实验配液计算器

动物实验计算换算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:

比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL, 一共给药动物10只,您使用的配方为 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline / PBS / ddH2O, 那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 100 μL DMSO ( 母液浓度为 20 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法: 取 100 μL DMSO 母液, 添加 400 μL PEG300 混匀澄清, 再加 50 μL Tween 80, 混匀澄清, 再加 450 μL Saline / PBS / ddH2O 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

方案所需的各类助溶剂如: DMSO, PEG300, PEG400, Tween 80, SBE-β-CD, 玉米油等, 均可在MolStrong网站点击购买。

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度: mg/ml;

DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL Saline/PBS/ddH2O,混匀澄清。

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础